Wong, Chi Kin

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism

Diabetes Treatment and ManagementNeuropeptides and Animal Physiology

Cited by 304

Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation

McLean, B. A., Wong, C. K., Campbell, J. E., Hodson, D. J., Trapp, S., & Drucker, D. J. (2021) · Endocrine Reviews

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 289

Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation

Wong, C. K., Yusta, B., Koehler, J. A., Baggio, L. L., McLean, B. A., Matthews, D., Seeley, R. J., & Drucker, D. J. (2022) · Cell Metabolism

Diabetes Treatment and ManagementGut microbiota and health

Cited by 138

Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits

Wong, C. K., & Drucker, D. J. (2025) · Journal of Clinical Investigation

Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases

Cited by 112

Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide

McLean, B. A., Wong, C. K., Kaur, K. D., Seeley, R. J., & Drucker, D. J. (2021) · JCI Insight

Diabetes Treatment and ManagementAtherosclerosis and Cardiovascular Diseases

Cited by 84

Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction

McLean, B. A., Wong, C. K., Kabir, M. G., & Drucker, D. J. (2022) · Molecular Metabolism

Diabetes Treatment and ManagementCardiac Ischemia and Reperfusion

Cited by 82

The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice

Forny Germano, L., Koehler, J. A., Baggio, L. L., Cui, F., Wong, C. K., Rittig, N., Cao, X., Matthews, D., & Drucker, D. J. (2024) · Molecular Metabolism

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 50

Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice

Hammoud, R., Kaur, K. D., Koehler, J. A., Baggio, L. L., Wong, C. K., Advani, K. E., Yusta, B., Efimova, I., Gribble, F. M., Reimann, F., et al. (2025) · JCI Insight

Diabetes Treatment and ManagementInflammatory Bowel Disease

Cited by 24

Reassessment of antibody-based detection of the murine T cell GLP-1 receptor

Wong, C. K., Yusta, B., Tong, J. C. L., Broichhagen, J., Hodson, D. J., & Drucker, D. J. (2025) · Cell Metabolism

Diabetes Treatment and ManagementReceptor Mechanisms and Signaling

Cited by 14